Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case? / Wested, Jakob; Minssen, Timo; Van Zimmeren, Esther .
I: Life Sciences Intellectual Property Review (LSIPR), Nr. 13/7 2018, 13.07.2018.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
AU - Wested, Jakob
AU - Minssen, Timo
AU - Van Zimmeren, Esther
PY - 2018/7/13
Y1 - 2018/7/13
N2 - As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.
AB - As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.
KW - Faculty of Law
KW - patents gene editing
KW - CRISPR-Cas 9
KW - European Patent Office
KW - Appeal
KW - Broad Institute
M3 - Journal article
JO - Life Sciences Intellectual Property Review (LSIPR)
JF - Life Sciences Intellectual Property Review (LSIPR)
IS - 13/7 2018
ER -
ID: 199125991